A New Solvent System (Cyclopentyl Methyl Ether–Water) in Process Development of Darifenacin HBr

This publication has 9 references indexed in Scilit:

• Toxicological Assessment of 2-Methyltetrahydrofuran and Cyclopentyl Methyl Ether in Support of Their Use in Pharmaceutical Chemical Process Development
  Organic Process Research & Development, 2011
• Darifenacin in the treatment of overactive bladder
  International Journal Of Clinical Practice, 2005
• Darifenacin: a novel M₃muscarinic selective receptor antagonist for the treatment of overactive bladder
  Expert Opinion on Investigational Drugs, 2004
• Efficient α-Halogenation of Carbonyl Compounds by N-Bromosuccinimide and N-Chlorosuccinimde
  Bulletin of the Korean Chemical Society, 2003
• Potential Benefits of Muscarinic M3 Receptor Selectivity
  European Urology Supplements, 2002
• M₃ muscarinic receptors mediate contraction of human urinary bladder
  British Journal of Pharmacology, 2002
• Muscarinic receptors of the urinary bladder: detrusor, urothelial and prejunctional
  Autonomic & Autacoid Pharmacology, 2002
• Modeling of Sonochemical Decomposition of CCl₄ in Aqueous Solutions
  Environmental Science & Technology, 1998
• Pregnancy, labor and delivery post spinal cord injury
  Spinal Cord, 1992